Issues of Survivorship and Rehabilitation in Soft Tissue Sarcoma

Abstract As the number of survivors of extremity soft tissue sarcoma increases, so does the need to understand the experience of survivors and develop measures, systems and services that support rehabilitation into normal life roles. Survivorship includes considerations of the physical, psychologica...

Full description

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) 2017-08, Vol.29 (8), p.538-545
Main Authors: Gerrand, C, Furtado, S
Format: Article
Language:English
Subjects:
Disability
Hematology, Oncology and Palliative Medicine
Humans
impairment
Radiology
rehabilitation
sarcoma
Sarcoma - rehabilitation
Sarcoma - therapy
Survival Rate
Survivors
survivorship
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract As the number of survivors of extremity soft tissue sarcoma increases, so does the need to understand the experience of survivors and develop measures, systems and services that support rehabilitation into normal life roles. Survivorship includes considerations of the physical, psychological and social domains, of which the physical sequelae of treatment are the best characterised in the literature. The survivorship experience may include disability, pain, lymphoedema, psychological problems, as well as difficulty with employment, relationships and lower quality of life. Rehabilitation strategies for extremity sarcoma patients must be personalised, holistic and begin early in the pathway, ideally before the first treatment intervention. The International Classification of Functioning, Disability and Health model is a useful framework for combining assessments, including objective outcome measures, which can be combined into a rehabilitation prescription. Research is needed to develop an evidence base for rehabilitation interventions to support patients with extremity soft tissue sarcoma.
ISSN:0936-6555
1433-2981
DOI:10.1016/j.clon.2017.04.001